2024 HCPCS Code C9094
Inj, sutimlimab-jome, 10 mg
| Notice | HCPCS C9094 terminated on September 30, 2022. |
| Short Description | Inj, sutimlimab-jome, 10 mg |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | October 01, 2022 |
| HCPCS Code Added Date | July 01, 2022 |
| HCPCS Pricing Indicator Code | 53 - Statute |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- C8928 - Tte w or w/o fol w/con,stres
- C8929 - Tte w or wo fol wcon,doppler
- C8930 - Tte w or w/o contr, cont ecg
- C8931 - Mra, w/dye, spinal canal
- C8932 - Mra, w/o dye, spinal canal
- C8933 - Mra, w/o&w/dye, spinal canal
- C8934 - Mra, w/dye, upper extremity
- C8935 - Mra, w/o dye, upper extr
- C8936 - Mra, w/o&w/dye, upper extr
- C8937 - Cad breast mri
- C8957 - Prolonged iv inf, req pump
- C9014 - Injection, cerliponase alfa
- C9015 - C-1 esterase, haegarda
- C9016 - Inj, triptorelin ext rel
- C9021 - Injection, obinutuzumab
- C9022 - Injection, elosulfase alfa
- C9023 - Inj testosterone undecanoate
- C9024 - Inj, daunorubicin-cytarabine
- C9025 - Injection, ramucirumab
- C9026 - Injection, vedolizumab
